Clinical Trials List
Protocol NumberCA209-796
Not yet recruiting
2018-09-27 - 2020-12-31
Phase II
Terminated2
ICD-10C11.0
Malignant neoplasm of superior wall of nasopharynx
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9147.0
Malignant neoplasm of superior wall of nasopharynx
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- HUAI-CHENG HUANG Division of Hematology & Oncology
- 陳贈成 Division of Otolaryngology
- 陳俊男 Division of Otolaryngology
- Hsiang-Fong Kao Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- RUEY-LONG HONG Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
41 participants
